Chimeric Therapeutics aspires to be a leader in cell therapy and to develop life-changing medicines for humankind
-
We put patients first
-
We demonstrate compassion and kindness to our patients and their families
-
We strive to do the right thing
-
Our people are our greatest assets
-
We are intellectually curious
-
Our science is data driven
-
We are collaborative
-
We value relationships based on trust and integrity
-
We will be good stewards of our investors’ capital
-
We will admit our mistakes and seek to learn from them
-
We aim to have fun
-
The value of our output must be worth more than the inputs
Latest Media Releases
Latest News
Company News /
by Peter Milios -
A year ago
23 Nov 2023 - Chimeric Therapeutics (ASX:CHM), an Australian company specialising in cell therapy, has reported significant in vitro findings for its chlorotoxin (CLTX) chimeric an…
Interviews /
by Peter Milios -
A year ago
25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
Company News /
by Abbey Phillipps -
A year ago
23 Oct 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Chimeric Therapeutics (ASX:CHM) and Sayona Mining (ASX:SYA; OTCQB:SYAXF).
Market Reports /
by Peter Milios -
A year ago
15 Aug 2023 - The price of gold has dropped to a five-month low due to improved expectations of a gentle economic slowdown in the US and a series of disappointing economic indicato…
Interviews /
by Tim McGowen -
A year ago
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the ti…
Market Reports /
by Peter Milios -
A year ago
26 Apr 2023 - At the closing bell, the S&P/ASX 200 was 0.08 per cent lower at 7,316.30, following weaker-than-expected core inflation figures for the first quarter. Mineral Resourc…
Market Reports /
by Peter Milios -
A year ago
26 Apr 2023 - According to the Australian Bureau of Statistics, annual inflation growth in the first quarter slowed to 7 per cent from the previous quarter's 7.8 per cent. This was…
Interviews /
by Tim McGowen -
A year ago
22 Mar 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on the company's trials.
Market Reports /
by Peter Milios -
A year ago
31 Jan 2023 - Australian shares fluctuated on Tuesday with a 0.4 per cent gain and later 0.2 per cent loss. Consumer stocks led the gains, up 2.3 per cent, while tech stocks weighe…
Market Reports /
by Peter Milios -
A year ago
23 Jan 2023 - Reports from UBS show that food prices at Australia’s largest supermarket chains, Coles and Woolworths, jumped by 9.2 per cent in the December quarter, up from 8.2 pe…
Market Reports /
by Peter Milios -
A year ago
dd Mmm 2023 - The ASX hit a fresh nine-month high this morning, after earnings from US tech companies helped lead US markets to big gains. However, since then, the ASX has fallen. …